Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Chief Executive Officer 57 2023-12-31
Director of Finance/CFO - 2023-04-02
Chief Operating Officer 46 -
Director TitleAgeSince
Chairman 68 2021-02-28
Director/Board Member 69 2020-12-31
Director/Board Member 45 2021-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-5.71%+43.61%+4.16% 281B
-0.28%-0.49%+21.71%-14.97% 66.39B
-0.03%-3.08%+28.97%+95.97% 8.13B
+1.30%+5.71%+2.36%-8.19% 8.15B
-1.88%+0.23%-2.53%+3.38% 4.52B
-1.14%+2.36%-24.59%+40.12% 3.8B
+8.33%+4.13%-2.52%+13.60% 3.42B
+1.84%-2.57%+34.65%+31.42% 2.58B
-1.01%+0.39%+2.10%-27.74% 1.93B
Average +0.65%-0.92%+11.53%+15.30% 42.24B
Weighted average by Cap. -0.97%-4.51%+36.67%+2.98%
Logo Recipharm publ AB
Recipharm AB (publ) is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). The Company's acivities are devided into four business segments: Advanced Delivery Systems, which develops and manufactures inhalation products and devices including integrated drug solutions, medical check valves and injection devices. Steriles, which manufactures sterile products, including the use of lyophilisation and blow-fillseal (BFS) technologies. Solids & Others, which manufactures non-sterile products, including tablets, capsules, semi-solids, liquids and powders but excluding inhalation products and Development & Licensing, which provides pharmaceutical development services, and manages Recipharm's patents, technologies, and drug product rights, as well as the development and manufacturing of drug substance (Active Pharmaceutical Ingredient, API). The Company operates worldwide.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!